If the FDA follows an advisory committee’s vote, it can potentially be a transformative step in the delivery of mental health ...

Nuplazid (pimavanserin) is already FDA-approved to treat psychosis caused by Parkinson's disease, but Acadia's hope to expanding that use to the Alzheimer's population were shot down by a complete ...

Amid the uproar over the firing of 18 inspectors general, a report offering a coda to the aducanumab approval episode has ...

14 For foods sold from bulk containers, which do not have a principal display panel, FDA proposes that the labeling display the Nutrition Info box plainly in view of the customer at the point of ...

The fallout from the F.D.A.’s rejection of MDMA-assisted treatment for PTSD worries researchers and experts who fear other ...

Two more minimalistic designs considered were reminiscent of the Nutrition Facts boxes on the back panel and called the amount of specific nutrients in a serving. In the proposed rule, FDA decided ...

An FDA panel is scheduled to review Novartis' (NVS) application seeking approval for the expanded use of its drug Fabhalta to treat adults with complement 3 glomerulopathy on February 24 ...

Last year, the FDA granted an accelerated approval to Sarepta’s gene therapy Elevydis after an advisory panel gave it a thumbs up by an 8-6 vote. As for Covis’ Makena, which was approved in ...

FDA has been considering FOP nutrition labeling ... the Nutrition Info box would appear on the upper third of the principal display panel. It would require an easy-to-read font and follow the ...